For CEO Kevin Gorman, the approval will be a vindication of many years work: he founded the company back in 1992, and suffered numerous setbacks along the way. Now Neurocrine Bioscience ...

Neurocrine Biosciences has a fifty-two week low of $105.18 and a fifty-two week high of $157.98. The firm has a market capitalization of $10.87 billion, a P/E ratio of 33.13, a P/E/G ratio of 0.77 ...

Also, Director Kevin Charles Gorman sold 5,844 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $116.69, for a total ...

Lionsgate TV Group chair/chief creative officer Kevin Beggs has been tapped to serve as the new chairman of the International Academy of Television Arts & Sciences, the org announced Thursday.

Kevin Bacon and Kyra Sedgwick are two of Hollywood’s most celebrated and beloved stars. With decades of success in film and television alongside a happy and long-lasting marriage they've ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LOVE Island All Stars’ Casey O’Gorman and Gabby Allen have lifted the lid on the fiery feud between Elma Pazar and Ekin-Su Cülcüloğlu. They revealed the tension in the villa was even worse ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The new indication brings the drug into direct competition with Ongentys from rival Neurocrine Biosciences, which was approved for the same use last year. Adamas noted that Gocovri (amantadine ...